A patient survey collaboration between Care by Design and Project CBD demonstrated that cannabis appears to be an effective pain management tool with few negative side effects. The study also found that a significant decrease in opiate usage among elderly patients while taking medical cannabis.
A pioneer neurologist, Dr. Ethan Russo, examines recent scientific data on migraine, fibromyalgia, irritable bowel, and other treatment-resistant syndromes that may respond to cannabinoid therapies.
Neuroscientist Greg Gerdeman, PhD, one of the rare professors to teach the endocannabinoid system in college, challenges health professionals and researchers to study cannabis science and therapeutics.
Brain science, the neurobiology of stress, and moving away from the drug abuse paradigm.
O’Shaughnessy’s (Winter 2015/16)—the journal that was instrumental in launching Project CBD six years ago—is now available.
Dr. Lester Grinspoon, Emeritus Professor of Psychiatry Harvard Medical School, urges an investigation of medical cannabis for players in the NFL.
Dozens servicemen and women marched to the White House to demand the president and other federal officials make medical marijuana accessible to veterans.
Care By Design asked thousands of patients about their use of CBD-rich cannabis and its impact on pain, discomfort, energy, mood, and overall wellbeing. Here's what they learned...
Cannabidiol is a safe, non-intoxicating, and non-addictive cannabis compound with significant therapeutic attributes, but CBD-drug interactions may be problematic in some cases.
Earth to NIDA: CBD provides well documented medical benefits. That is a fact. Not a “potential promise.”